top of page

NEWS

This page features the latest from NeoVac. Press releases, milestones, conference news and selected articles. For scientific outputs, please see Publications.

1 

NeoVac Announces Positive Phase I/II Results Demonstrating Superior Safety Profile of Next-Generation mRNA-LNP Vaccine Platform

First-in-Human Phase I/II Results of Proprietary Lipid Nanoparticle Delivery Platform Advance the Potential of mRNA Therapeutics and Preventive Vaccines

​​

Read More

2

NeoVac announces new CEO

NeoVac, a leading pharmaceutical company specialising in innovative lipid nanoparticle (LNP) technologies for mRNA therapeutics, is pleased to announce the appointment of Dr. Jan H. Egberts as Chief Executive Officer to guide the next phase of growth for the company

​​

Read More
bottom of page